Enzymatic Debridement

Original Research

Clostridial Collagenase for the Management of Diabetic Foot Ulcers: Results of Four Randomized Controlled Trials

08/25/2017

John C. Lantis II, MD, FACS;

Ian L. Gordon ;

08/25/2017

Wounds

Original Research

Enzymatic Debridement of Chronic Nonischemic Diabetic Foot Ulcers: Results of a Randomized, Controlled Trial

05/03/2017

Jaime E. Dickerson Jr.;

Herbert B. Slade ;

Perry Mayer , MB, BCh, CCFP;

Darrell L. Lange ;

Joseph M. Caporusso , DPM;

John Randolph Clements , DPM, FACFAS;

Patrick S. Agnew , DPM, FACFAS;

Juan Carlos Jimenez ;

The aim of this randomized, controlled multicenter trial was to evaluate the clinical outcomes associated with the use of clostridial collagenase ointment (CCO) for up to 12 weeks in 215 patients with type 1 or type 2 diabetes mellitus and a...

The aim of this randomized,...

05/03/2017

Wounds

Original Research

Decreased Incidence of Hypertrophic Burn Scar Formation with the Use of Collagenase, an Enzymatic Debriding Agent

12/01/2005

Arnold Luterman ;

Karen E. Frye ;

12/01/2005

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Enzymatic Debridement

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products